Haemonetics Corporation Amortization
Haemonetics Corporation (HAE) reported Amortization of $21.61 million for the 9-month period ending 2023-12-30, per its 10-Q filed 2024-02-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2024-02-08
- Haemonetics Corporation amortization for the quarter ending 2023-12-30 was $6.91M, a 14.45% decline year-over-year.
- Haemonetics Corporation amortization for the quarter ending 2022-12-31 was $8.08M, a 33.52% decline year-over-year.
- Haemonetics Corporation amortization for the quarter ending 2022-10-01 was $8.22M, a 27.89% decline year-over-year.
- Haemonetics Corporation amortization for the quarter ending 2022-07-02 was $8.37M, a 32.41% decline year-over-year.
- Haemonetics Corporation amortization for fiscal 2021 was -$25.70M.
- Haemonetics Corporation amortization for fiscal 2020 was -$75.75M.
- Haemonetics Corporation amortization for fiscal 2019 was -$40.30M.
- Haemonetics Corporation amortization for fiscal 2018 was -$26.01M, a 195.96% decline from fiscal 2017.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month | Amortization 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-30 | $6.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $21.61M 10-Q · filed 2024-02-08 | |||
| 2023-09-30 | $14.70M 10-Q · filed 2023-11-02 | ||||
| 2022-12-31 | $8.08M 10-Q · filed 2023-02-07 | $16.30M derived: sum of 2 quarters · filed 2023-02-07 | $24.67M 10-Q · filed 2024-02-08 | ||
| 2022-10-01 | $8.22M 10-Q · filed 2022-11-08 | $16.59M 10-Q · filed 2023-11-02 | |||
| 2022-07-02 | $8.37M 10-Q · filed 2022-08-10 | ||||
| 2022-01-01 | $12.15M 10-Q · filed 2023-02-07 | $23.55M derived: sum of 2 quarters · filed 2023-02-07 | $35.93M 10-Q · filed 2023-02-07 | -$13.97M derived: sum of 4 quarters · filed 2023-02-07 | |
| 2021-10-02 | $11.40M 10-Q · filed 2022-11-08 | $23.78M 10-Q · filed 2022-11-08 | -$26.12M derived: sum of 3 quarters · filed 2022-11-08 | -$18.32M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-07-03 | $12.38M 10-Q · filed 2022-08-10 | -$37.52M derived: sum of 2 quarters · filed 2022-08-10 | -$29.72M derived: sum of 3 quarters · filed 2022-08-10 | -$21.58M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-04-03 | -$49.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-26 | -$42.09M derived: sum of 2 quarters · filed 2022-02-08 | -$33.96M derived: sum of 3 quarters · filed 2022-02-08 | -$25.70M 10-K · filed 2021-05-26 | |
| 2020-12-26 | $7.80M 10-Q · filed 2022-02-08 | $15.94M derived: sum of 2 quarters · filed 2022-02-08 | $24.20M 10-Q · filed 2022-02-08 | -$69.23M derived: sum of 4 quarters · filed 2022-02-08 | |
| 2020-09-26 | $8.14M 10-Q · filed 2021-11-09 | $16.40M 10-Q · filed 2021-11-09 | -$77.03M derived: sum of 3 quarters · filed 2021-11-09 | -$71.26M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-27 | $8.26M 10-Q · filed 2021-08-11 | -$85.17M derived: sum of 2 quarters · filed 2021-08-11 | -$79.40M derived: sum of 3 quarters · filed 2021-08-11 | -$73.46M derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-28 | -$93.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-26 | -$87.66M derived: sum of 2 quarters · filed 2021-05-26 | -$81.72M derived: sum of 3 quarters · filed 2021-05-26 | -$75.75M 10-K · filed 2021-05-26 | -$25.75M 10-K · filed 2020-05-20 |
| 2019-12-28 | $5.77M 10-Q · filed 2021-02-02 | $11.71M derived: sum of 2 quarters · filed 2021-02-02 | $17.68M 10-Q · filed 2021-02-02 | -$41.28M derived: sum of 4 quarters · filed 2021-05-26 | |
| 2019-09-28 | $5.93M 10-Q · filed 2020-11-04 | $11.91M 10-Q · filed 2020-11-04 | -$47.05M derived: sum of 3 quarters · filed 2021-05-26 | -$40.92M derived: sum of 4 quarters · filed 2021-05-26 | |
| 2019-06-29 | $5.97M 10-Q · filed 2020-08-04 | -$52.99M derived: sum of 2 quarters · filed 2021-05-26 | -$46.86M derived: sum of 3 quarters · filed 2021-05-26 | -$40.62M derived: sum of 4 quarters · filed 2021-05-26 | |
| 2019-03-30 | -$58.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-26 | -$52.83M derived: sum of 2 quarters · filed 2021-05-26 | -$46.60M derived: sum of 3 quarters · filed 2021-05-26 | -$40.30M 10-K · filed 2021-05-26 | $24.80M 10-K · filed 2019-05-22 |
| 2018-12-29 | $6.13M 10-Q · filed 2020-02-04 | $12.37M derived: sum of 2 quarters · filed 2020-02-04 | $18.67M 10-Q · filed 2020-02-04 | -$26.85M derived: sum of 4 quarters · filed 2020-05-20 | |
| 2018-09-29 | $6.24M 10-Q · filed 2019-11-01 | $12.54M 10-Q · filed 2019-11-01 | -$32.98M derived: sum of 3 quarters · filed 2020-05-20 | -$26.47M derived: sum of 4 quarters · filed 2020-05-20 | |
| 2018-06-30 | $6.30M 10-Q · filed 2019-08-06 | -$39.21M derived: sum of 2 quarters · filed 2020-05-20 | -$32.71M derived: sum of 3 quarters · filed 2020-05-20 | -$26.20M derived: sum of 4 quarters · filed 2020-05-20 | |
| 2018-03-31 | -$45.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-20 | -$39.01M derived: sum of 2 quarters · filed 2020-05-20 | -$32.50M derived: sum of 3 quarters · filed 2020-05-20 | -$26.01M 10-K · filed 2020-05-20 | $26.01M 10-K · filed 2018-05-23 |
| 2017-12-30 | $6.51M 10-Q · filed 2019-02-05 | $13.01M derived: sum of 2 quarters · filed 2019-02-05 | $19.50M 10-Q · filed 2019-02-05 | $26.00M derived: sum of 4 quarters · filed 2019-05-22 | |
| 2017-09-30 | $6.50M 10-Q · filed 2018-11-06 | $12.99M 10-Q · filed 2018-11-06 | $19.49M derived: sum of 3 quarters · filed 2019-05-22 | $26.02M derived: sum of 4 quarters · filed 2019-05-22 | |
| 2017-07-01 | $6.49M 10-Q · filed 2018-08-07 | $12.99M derived: sum of 2 quarters · filed 2019-05-22 | $19.52M derived: sum of 3 quarters · filed 2019-05-22 | $26.52M derived: sum of 4 quarters · filed 2019-05-22 | |
| 2017-04-01 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-22 | $13.03M derived: sum of 2 quarters · filed 2019-05-22 | $20.03M derived: sum of 3 quarters · filed 2019-05-22 | $27.11M 10-K · filed 2019-05-22 | |
| 2016-12-31 | $6.53M 10-Q · filed 2018-02-06 | $13.54M derived: sum of 2 quarters · filed 2018-02-06 | $20.61M 10-Q · filed 2018-02-06 | $27.38M derived: sum of 4 quarters · filed 2018-05-23 | |
| 2016-10-01 | $7.01M 10-Q · filed 2017-11-07 | $14.08M 10-Q · filed 2017-11-07 | $20.85M derived: sum of 3 quarters · filed 2018-05-23 | $28.23M derived: sum of 4 quarters · filed 2018-05-23 | |
| 2016-07-02 | $7.08M 10-Q · filed 2017-08-07 | $13.84M derived: sum of 2 quarters · filed 2018-05-23 | $21.23M derived: sum of 3 quarters · filed 2018-05-23 | $28.63M derived: sum of 4 quarters · filed 2018-05-23 | |
| 2016-04-02 | $6.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-23 | $14.15M derived: sum of 2 quarters · filed 2018-05-23 | $21.55M derived: sum of 3 quarters · filed 2018-05-23 | $28.96M 10-K · filed 2018-05-23 | |
| 2015-12-26 | $7.39M 10-Q · filed 2017-02-06 | $14.79M derived: sum of 2 quarters · filed 2017-02-06 | $22.19M 10-Q · filed 2017-02-06 | ||
| 2015-09-26 | $7.40M 10-Q · filed 2016-11-07 | $14.80M 10-Q · filed 2016-11-07 | |||
| 2015-06-27 | $7.41M 10-Q · filed 2016-08-01 | ||||
| 2015-03-28 | $30.18M 10-K · filed 2017-05-24 | ||||
| 2014-03-29 | $28.06M 10-K · filed 2016-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |